nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—ALB—focal segmental glomerulosclerosis	0.475	1	CbGaD
Norethindrone—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.115	0.242	CbGbCtD
Norethindrone—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.115	0.242	CbGbCtD
Norethindrone—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0865	0.181	CbGbCtD
Norethindrone—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0698	0.146	CbGbCtD
Norethindrone—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0563	0.118	CbGbCtD
Norethindrone—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0337	0.0707	CbGbCtD
Norethindrone—Carcinoma—Cyclosporine—focal segmental glomerulosclerosis	0.00453	0.0935	CcSEcCtD
Norethindrone—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.0486	CcSEcCtD
Norethindrone—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.048	CcSEcCtD
Norethindrone—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.0459	CcSEcCtD
Norethindrone—Digestion impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.0422	CcSEcCtD
Norethindrone—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.0399	CcSEcCtD
Norethindrone—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.0336	CcSEcCtD
Norethindrone—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.0331	CcSEcCtD
Norethindrone—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0324	CcSEcCtD
Norethindrone—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.0321	CcSEcCtD
Norethindrone—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0215	CcSEcCtD
Norethindrone—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0213	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.0212	CcSEcCtD
Norethindrone—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.000977	0.0202	CcSEcCtD
Norethindrone—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.000977	0.0202	CcSEcCtD
Norethindrone—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00094	0.0194	CcSEcCtD
Norethindrone—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000897	0.0185	CcSEcCtD
Norethindrone—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000864	0.0178	CcSEcCtD
Norethindrone—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000781	0.0161	CcSEcCtD
Norethindrone—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000763	0.0158	CcSEcCtD
Norethindrone—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000754	0.0156	CcSEcCtD
Norethindrone—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000752	0.0155	CcSEcCtD
Norethindrone—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00075	0.0155	CcSEcCtD
Norethindrone—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000723	0.0149	CcSEcCtD
Norethindrone—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00069	0.0143	CcSEcCtD
Norethindrone—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000687	0.0142	CcSEcCtD
Norethindrone—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000687	0.0142	CcSEcCtD
Norethindrone—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000675	0.0139	CcSEcCtD
Norethindrone—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000607	0.0125	CcSEcCtD
Norethindrone—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000602	0.0124	CcSEcCtD
Norethindrone—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000589	0.0122	CcSEcCtD
Norethindrone—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000587	0.0121	CcSEcCtD
Norethindrone—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000581	0.012	CcSEcCtD
Norethindrone—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000518	0.0107	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000505	0.0104	CcSEcCtD
Norethindrone—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000488	0.0101	CcSEcCtD
Norethindrone—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000488	0.0101	CcSEcCtD
Norethindrone—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000474	0.00979	CcSEcCtD
Norethindrone—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000441	0.00911	CcSEcCtD
Norethindrone—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000434	0.00896	CcSEcCtD
Norethindrone—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000429	0.00887	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000421	0.0087	CcSEcCtD
Norethindrone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000421	0.00869	CcSEcCtD
Norethindrone—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000399	0.00824	CcSEcCtD
Norethindrone—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000388	0.008	CcSEcCtD
Norethindrone—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000386	0.00796	CcSEcCtD
Norethindrone—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000359	0.00742	CcSEcCtD
Norethindrone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00035	0.00723	CcSEcCtD
Norethindrone—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000345	0.00713	CcSEcCtD
Norethindrone—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000323	0.00666	CcSEcCtD
Norethindrone—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00031	0.00641	CcSEcCtD
Norethindrone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000308	0.00635	CcSEcCtD
Norethindrone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000307	0.00635	CcSEcCtD
Norethindrone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000306	0.00631	CcSEcCtD
Norethindrone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.00598	CcSEcCtD
